Atlas Trials

A Pharmacokinetic Study of the Effect of Itraconazole Exposure to Orvepitant in Healthy Volunteers

Clinical trial NCT03535662 · COMPLETED

Trial details

NCT number
NCT03535662
Sponsor
Nerre Therapeutics Ltd.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Pharmacokinetic Study in Healthy Male Volunteers
Start date
2018-06-08
Primary completion
2018-08-09
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.